Into the Unknown: Regulatory Perspective on Identifying Optimized Dosages of Oncology Radiopharmaceutical Therapies

William F. Maguire

Division of Oncology I, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD

Donika Plyku

Division of Imaging and Radiation Medicine, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD

Sundeep Agrawal

Anthony Fotenos

Division of Imaging and Radiation Medicine, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD

Christy S. John

Division of Imaging and Radiation Medicine, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD

Haleh Saber

Division of Hematology Oncology Toxicology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD

Stacy S. Shord

Division of Cancer Pharmacology II, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD

Alice V. Cheuk

Division of Imaging and Radiation Medicine, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD

August Hofling

Division of Imaging and Radiation Medicine, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD

Daniel L. Suzman

Division of Oncology I, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD